Registry Study for Cancer and Benign Diseases Treated with Radiation
This is a registry study collecting information about patients who have received or were considered for radiation treatment for cancer or non-cancerous (benign) conditions. The study aims to understand the long-term results of these treatments. Researchers will look at information from your medical records, including your diagnosis, treatments, and how you're doing over time. They will also compare these outcomes to a national cancer database. You might be able to join if you are between 18 and 99 years old and received or were evaluated for radiation therapy since 2000. People with similar diagnoses who chose other treatments like surgery or chemotherapy might also be included. The study is looking to enroll 10,000 participants. The main goal is to analyze your quality of life up to 10 years after treatment.
- Study design
- This is an observational study, meaning researchers will collect information from your existing medical records. It aims to include 10,000 participants.
- What's involved
- Researchers will collect information from your medical records after your standard doctor visits. You will not have any extra appointments or procedures for this study.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your quality of life will be analyzed for up to 10 years after treatment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- David J Sher, MD, MPH · PRINCIPAL_INVESTIGATOR · University of Texas Southwestern Medical Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Quality of Life Analysis10 years
The quality of life questionnaire will be used as a standardized instrument to measure the health outcome.Its provides a simple descriptive profile and a single index value for health status. The US version of the EQ-5D will be used, to enable mapping of general HR-QOL scores from EQ-5D scores into health state utility scores (ranging from 0 to 100) for the US population.Analyses will be performed for all subjects having received treatment for benign and cancer tumors. Information gained from this could lead to improved medical care for them. By performing comparative study for subgroups of patients with similar diseases but not treated with radiation therapy, potential benefits and risks of radiation therapy may be better delineated.